Previous Article | Next Article 
Journal of Virology, November 2001, p. 10431-10445, Vol. 75, No. 21
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.21.10431-10445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of Genes Involved in the Host
Response to Neurovirulent Alphavirus Infection
Christine
Johnston,1
Wenxia
Jiang,1
Tearina
Chu,2,
and
Beth
Levine1,*
Department of Medicine, Columbia University
College of Physicians & Surgeons, New York, New York
10032,1 and Liver Research Center,
Albert Einstein College of Medicine, Bronx, New York
104612
Received 20 February 2001/Accepted 24 July 2001
 |
ABSTRACT |
Single-amino-acid mutations in Sindbis virus proteins can convert
clinically silent encephalitis into uniformly lethal disease. However,
little is known about the host gene response during avirulent and
virulent central nervous system (CNS) infections. To identify candidate
host genes that modulate alphavirus neurovirulence, we utilized
GeneChip Expression analysis to compare CNS gene expression in mice
infected with two strains of Sindbis virus that differ by one amino
acid in the E2 envelope glycoprotein. Infection with Sindbis virus,
dsTE12H (E2-55 HIS), resulted in 100% mortality in 10-day-old mice,
whereas no disease was observed in mice infected with dsTE12Q (E2-55
GLN). dsTE12H, compared with dsTE12Q, replicated to higher titers in
mouse brain and induced more CNS apoptosis. Infection with the
neurovirulent dsTE12H strain was associated with both a greater number
of host genes with increased expression and greater changes in levels
of host gene expression than was infection with the nonvirulent dsTE12Q
strain. In particular, dsTE12H infection resulted in greater increases
in the levels of mRNAs encoding chemokines, proteins involved in
antigen presentation and protein degradation, complement proteins,
interferon-regulated proteins, and mitochondrial proteins. At least
some of these increases may be beneficial for the host, as evidenced by
the demonstration that enforced expression of the antiapoptotic
mitochondrial protein peripheral benzodiazepine receptor (PBR) protects
neonatal mice against lethal Sindbis virus infection. Thus, our
findings identify specific host genes that may play a role in the host
protective or pathologic response to neurovirulent Sindbis virus infection.
 |
INTRODUCTION |
The host response to viral
infection represents a complex orchestration of divergent pathways
designed to eradicate the virus and benefit the host. However, many
pathways that are involved in antiviral defense can also have untoward
effects on the host, including cytotoxic T-lymphocyte responses,
cytokine responses, and apoptosis, resulting in either dysfunction or
death of infected or neighboring uninfected cells. The potential for
host pathology due to vigorous antiviral responses is of particular
importance for tissues containing vital nonrenewable cell populations,
such as the central nervous system (CNS) (reviewed in reference
50). Therefore, an important challenge in understanding
the pathogenesis of CNS viral infections is the elucidation of specific
host responses that play protective and/or pathologic roles.
With the use of high-density DNA microarrays, it is possible to define
changes in gene expression that underlie the host response to viral
pathogens and to gain specific insights into the molecular nature of
the host pathways that govern viral pathogenesis. To date, however, the
use of DNA microarray technology to measure host gene expression during
viral infections has been restricted primarily to cells grown in
culture. For example, previous studies have described alterations of
cellular mRNAs in human foreskin fibroblasts infected with human
cytomegalovirus (64), in CD4-positive T cells infected
with human immunodeficiency virus type 1 (18), and in
human embryonic lung cells infected with herpes simplex virus type 1 (48). However, little is known about the molecular profile
of the host transcriptional response to viral infections in the intact
host or about the precise physiologic role that alterations in host
gene expression may play in viral pathogenesis.
Sindbis virus, a message-sense RNA virus in the alphavirus genus,
provides an excellent model system for studying the complex interrelationships between host gene expression and viral pathogenesis. Both host factors and specific viral genetic determinants have been
identified that play a critical role in regulating the ability of
Sindbis virus to cause neurologic disease in mice. The most important
known host factor is age; wild-type Sindbis virus results in a rapidly
fatal encephalomyelitis in newborn mice but produces no clinically
apparent disease in older mice (30). Interestingly, wild-type Sindbis virus can undergo neuroadaptive mutations which overcome the host age-dependent restriction to virulence (22, 38), and a single-amino-acid mutation at position 55 of the E2
envelope glycoprotein can produce lethal disease in older mice (59, 60). Thus, by using DNA microarray technology to
compare the host cellular response in different aged mice infected
with Sindbis virus or in mice infected with different strains
of Sindbis virus that vary in neurovirulence, it may be possible to
identify host genes that are important in modulating viral pathogenesis.
An additional advantage of the Sindbis virus model system is that an
efficient strategy has already been developed for studying the effects
of specific host cell genes on viral neuropathogenesis (reviewed in
reference 24). The strategy involves the use of chimeric
recombinant double-subgenomic Sindbis virus constructs that
express heterologous genes in virally infected neurons in vivo.
Using this approach, it has been shown that enforced expression of
several different host cell genes, including bcl-2
(37) beclin 1 (41), bax
(39), and SMN (31), protects mice
against fatal Sindbis virus encephalitis whereas enforced expression of
other host genes increases the likelihood of animal death (H. H. Jiang, W. Jiang, and B. Levine, unpublished data). Therefore,
this approach could potentially be useful in determining whether
cellular mRNAs that are found to be differentially regulated in
virulent and avirulent Sindbis virus infections play a
protective or pathologic role in viral pathogenesis.
In this study, we used a Sindbis virus mouse encephalitis model to
study how the host cellular gene response differs in a nonlethal and a
lethal infection. Our findings identified specific host genes that are
differentially regulated during neurovirulent Sindbis virus infection.
Furthermore, we used the Sindbis virus vector system to show that
increased expression of one of these genes, PBR (encoding peripheral
benzodiazepine receptor), plays a protective role for the host in
Sindbis virus encephalitis.
 |
MATERIALS AND METHODS |
Recombinant virus strains.
Previously described recombinant
strains of double-subgenomic Sindbis viruses,
dsTE12H (formerly referred to as dsTE12) (37) and
dsTE12Q (29) were used for most experiments. To
construct recombinant chimeric Sindbis viruses expressing mouse PBR, a
509-bp fragment containing the open reading frame of the mouse PBR gene was amplified by PCR from cDNA prepared from dsTE12H-infected mouse
brains, adding BstEII restriction sites to the upstream and
downstream primer and a flag epitope sequence to the upstream primer.
The mouse PBR gene was cloned into the BstEII sites of dsTE12Q to generate plasmid dsTE12Q/PBR, and the correct
sequence of the mouse PBR gene insert was confirmed by sequencing. A
control chimeric viral cDNA, dsTE12Q/PBR-control, was also
constructed in which the start codon of the PBR gene was deleted.
Stock viruses (dsTE12Q, dsTE12H, dsTE12Q/PBR, and
dsTE12Q/PBRcontrol) were produced from viral cDNA clones as
previously described (37) and stock titers were determined
by plaque assay titer determination on BHK-21 cells.
Animal studies.
The right cerebral hemispheres of 1- and
10-day-old CD1 mice (Charles River) were inoculated with 1,000 PFU of
virus in 0.03 ml of Hanks' balanced salt solution. A 0.03-ml volume of
Hanks' balanced salt solution was used for mock infections. For
mortality studies, three to five separate litters were inoculated with
each virus and the mice were observed daily for 21 days to monitor survival. For RNA isolation, brains were dissected at 1, 2, and 3 days
(24, 48, and 72 h) after inoculation (for reverse
transcription-PCR [RT]-PCR analysis) and at 3 days (66 h) after
inoculation (for GeneChip expression analysis). The left hemisphere
of the brain was rapidly frozen and stored at
80°C. The right
cerebral hemisphere was fixed by immersion in 4% paraformaldehyde. For
virus titer determination experiments, the left cerebral hemisphere was
used to make a freeze-thaw 10% homogenate in Hanks' balanced salt
solution for subsequent plaque assay on BHK-21 cells.
Histopathology.
The right cerebral hemispheres of
paraformaldehyde-fixed mouse brains were embedded in paraffin, and a
series of 4-µm-thick sagittal sections were cut from medial to
lateral. For each dsTE12Q- and dsTE12H-infected brain,
sequential sections were examined by hematoxylin and eosin (H & E)
staining to detect histopathology, terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL) staining to detect apoptosis, and immunoperoxidase staining to detect Sindbis virus antigen, mouse PBR, mouse IRF-7, and
mouse MCP-1. For each dsTE12Q/PBR- and dsTE12Q/PBR
control-infected brain, sequential sections were examined by H & E
staining, TUNEL, and immunoperoxidase staining to detect Sindbis virus
antigen and flag-epitope-tagged mouse PBR. TUNEL staining was
performed using the ApopTag peroxidase in situ apoptosis
detection kit (Intergen). Immunostaining to detect Sindbis virus
antigen was performed using a polyclonal anti-Sindbis virus antibody
(1:400 dilution) and the avidin-biotin peroxidase method
(Vectastain ABC kit; Vector Laboratories). A similar method was
used to detect mouse PBR with a polyclonal rabbit anti-PBR antibody
(1:150 dilution; Trevigen), IRF-7 with a polyclonal rabbit anti-murine
IRF-7 antibody (1:50 dilution; Zymed Laboratories), MCP-1 with a
polyclonal rabbit anti-murine MCP-1 antibody (1:50 dilution;
PeproTech), and the flag epitope with monoclonal anti-flag antibody M2
(20 µg/ml; Sigma). The number of TUNEL-positive cells in each
sagittal section of dsTE12Q/PBR- and
dsTE12H/PBRcontrol-infected brains was counted at ×20
magnification by an observer blinded to the treatment group. Results
are expressed as the mean number of apoptotic cells per ×20
magnification field.
GeneChip expression analysis sample preparation and
hybridization.
RNA was prepared for GeneChip expression
analysis as specified by the manufacturer (Affymetrix) and as described
in previously published protocols (14, 35, 64). Briefly,
total RNA was isolated from the left hemispheres of brains dissected 3 days after virus infection using TRIzol reagent (Gibco/BRL). RNA
from six mice per treatment group was pooled and used for GeneChip expression analysis. Poly(A)+ mRNA was isolated from
200 µg of pooled total RNA using Oligotex Direct mRNA kit
(Qiagen). cDNA was synthesized from 1 µg of poly(A)+
mRNA using a T7 (dT)24 high-pressure liquid
chromatography-purified primer (GENSET) and SuperScript choice
system (Gibco/BRL). Biotin-labeled cRNA was generated from 1 µg of
cDNA using the RNA transcript labeling kit (ENZO). RNeasy mini-kits
(Qiagen) were used to remove the unincorporated nucleoside
triphosphates. The samples were precipitated in ethanol and resuspended
in diethylpyrocarbonate-treated H2O at a concentration of
0.5 to 1 µg/µl. Samples were fragmented to 50 to 200 bp in 5×
fragmentation buffer (200 mM Tris acetate [pH 8.1], 500 mM potassium
acetate, 150 mM magnesium acetate) for 35 min at 95°C. The samples
were hybridized to the Murine 6500 GeneChip subarrays A, B, C, and
D (Affymetrix) overnight, washed, and stained as previously described
(63, 64).
Data analysis.
The data collected after hybridization of
biotin-labeled cRNA from each treatment group was analyzed using
GeneChip Suite software. Internal controls for hybridization
intensity and cRNA synthesis were included on each chip and have been
discussed elsewhere (14). Samples were normalized to
glyceraldehyde phosphate dehydrogenase, actin, and 18S rRNA levels. The
Absolute Analysis algorithm was used to calculate whether genes were
"absent" or "present" based on previously described parameters
(64). To calculate fold changes in genes in two different
samples, the Comparison Analysis algorithm (Affymetrix) was used
(64). Three different comparison analyses were performed,
including one with cRNA from mock-infected brains as the baseline
sample and cRNA from dsTE12Q-infected brains as the experimental
sample (QvM), one with cRNA from mock-infected brains as the baseline
sample and cRNA from dsTE12H-infected brains as the experimental
sample (HvM), and one with cRNA from dsTE12Q-infected brains as the
baseline sample and cRNA from dsTE12Q-infected brains as the
experimental sample (HvQ). Genes which were "absent" in the
absolute analysis of the baseline sample and "decreasing" in the
experimental sample on comparison analysis were considered false
positives. Genes which were "absent" in the absolute analysis of
the experimental sample and also "increasing" in the experimental sample upon comparison analysis were also considered false positives.
Analysis of CNS gene expression by RT-PCR.
Total RNA was
extracted using TRIzol Reagent, and poly(A) RNA was isolated using an
Oligotex Direct mRNA kit (Qiagen) from triplicate mouse brains on
days 1, 2, and 3 after mock infection or infection with 1,000 PFU of
dsTE12H or dsTE12Q, intracerebrally. A 1-µg portion of
poly(A)+ RNA was used to synthesize cDNA with avian
myeloblastosis virus reverse transcriptase (Boehringer Mannheim) and an
oligo(dT) primer (Boehringer Mannheim), and PCR was performed as
described previously (62) to detect the Sindbis virus E2
glycoprotein gene (plus-strand primer [8607-8626],
5'-GGATCGTCTGGCAGAAGCAA-3'; minus-strand primer [8893-8912], 5'-AAGCCTTCTACACGGTCCTG-3'), murine
MCP-1 (plus-strand primer, 5'-ACCAAGCTCAAGAGAGAGGT-3'; minus-strand
primer, 5'-CTGGATTCACAGAGAGGGAA-3'), murine IRF-7
(plus-strand primer, 5'-CAGCGAGTGCTGTTTGGAGA-3'; minus-strand primer, 5'-ACTGCAGAACCTGAAGCAAGAG-3'),
murine PBR (plus-strand primer, 5'-TCATGGGAGCCTACTTTGTG-3';
minus-strand primer, 5'-CAGGTAAGGATACAGCAAGC-3'), and
the constituitively expressed cellular gene, glyceraldehyde phosphate
dehydrogenase (plus-strand primer,
5'-ACCACCATGGAGAAGGCTGG-3'; minus-strand primer,
5'-CTCAGTGTAGCCCAGGATGC-3'). Serial dilutions of positive
controls for each gene of interest were amplified at 20, 25, 30, and 35 cycles to determine the optimal number of amplification cycles that
resulted in a linear relationship between the initial RNA input and PCR
product. Twenty-five cycles of amplification was used in each PCR in
the data shown in Fig. 8A.
 |
RESULTS |
dsTE12H produces fatal disease and dsTE12Q produces
asymptomatic disease in 10-day-old CD1 mice.
To compare the host
gene response during virulent and avirulent CNS infections, we studied
the pathogenesis of two different strains of Sindbis virus,
dsTE12H and dsTE12Q. dsTE12H and dsTE12Q are both
recombinant strains of Sindbis virus that contain duplicated internal
subgenomic promoters. Although viral replication is
somewhat attenuated by the presence of a duplicated
subgenomic promoter, we chose to use these strains because
of their utility as vectors for expressing candidate host pathogenesis
regulatory genes in neurons in vivo. The strains dsTE12Q and
dsTE12H differ by only 1 amino acid at position 55 in the E2
envelope glycoprotein; dsTE12Q contains a wild-type glutamine at
E2-55 and dsTE12H contains a histidine substitution. The histidine
substitution at E2-55 has been previously shown to be an important
determinant of neurovirulence for older mice in
non-double-subgenomic recombinant strains of Sindbis virus
(59, 60). Similarly, we found that intracerebral inoculation of 1,000 PFU of dsTE12H resulted in 100% mortality in
10-day-old mice within 7 days after infection whereas no mortality or
clinically apparent disease was observed in mice infected with dsTE12Q (Fig. 1). These data
demonstrate that in the double-subgenomic strain of Sindbis
virus, a histidine mutation at position E2-55 confers neurovirulence in
10-day-old mice.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Survival curve of 10-day-old mice infected with 1,000 PFU dsTE12H or dsTE12Q. Data represent combined survival
probabilities for three independent litters with 10 to 12 mice per
litter.
|
|
dsTE12H replicates to higher levels and causes increased
apoptosis in the brains of 10-day-old mice.
In parallel with
increased mortality, we found higher levels of Sindbis virus
replication in the brains of mice infected with dsTE12H compared to
the brains of mice infected with dsTE12Q (Fig. 2). By day 3 after infection (when most
dsTE12H-infected mice are moribund), mean viral titers were
greater than 109 PFU per g of brain in mice infected with
dsTE12H. In dsTE12Q-infected mice, viral titers peaked at 1 day
postinfection at 107 PFU per g of brain and declined
gradually thereafter. More extensive viral antigen staining was also
observed in the brains of mice infected with dsTE12H than in the
brains of mice infected with dsTE12Q (representative
photomicrographs are shown in Fig. 3A and
B). Despite greater numbers of viral
antigen-positive cells in the brains of dsTE12H-infected mice,
the tropism of the two Sindbis virus strains did not differ. In both
dsTE12H- and dsTE12Q-infected mouse brains, neurons were the
most prominent cell type infected and virus-infected foci were
identified most frequently in the posterior neocortex, hippocampus,
colliculus, and striatum.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Viral growth of dsTE12H and dsTE12Q in mouse
brain. Each data point represents the geometric mean viral titer and
standard error of the mean for three mouse brains.
|
|

View larger version (121K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoperoxidase labeling to detect Sindbis virus
antigen (A and B) and TUNEL labeling to detect apoptotic nuclei (C and
D) in the brains of dsTE12H-infected (A and C) and
dsTE12Q-infected (B and D) mice. Representative sections are shown
from the superior colliculus region 3 days after virus infection.
Magnification, ×243.
|
|
We analyzed adjacent mouse brain sections by immunohistochemistry to
detect Sindbis virus antigen, by H & E staining to detect
neuronal
pathology, and by TUNEL staining to detect apoptotic
nuclei on days 1, 2, and 3 after infection (Fig.
3). In dsTE12Q-infected
brains,
pathology and TUNEL-positive cells were rarely observed
in the regions
of viral antigen-positive cells (Fig.
3B and D
and data not shown). In
contrast, in dsTE12H-infected brains,
virus-infected foci
displayed numerous pyknotic neuronal nuclei
and numerous TUNEL-positive
neuronal nuclei (Fig.
3A and C and
data not shown). This observation is
consistent with a previous
report indicating that a histidine mutation
at E2-55 in a similar
background strain of a
non-double-subgenomic Sindbis virus results
in increased
neuronal apoptosis in 2-week-old mice (
40). Surprisingly,
very little perivascular cuffing or other evidence of inflammation
was
observed in the brains of both dsTE12Q- and
dsTE12H-infected
mice.
Thus, the neurovirulent strain, dsTE12H replicates to higher titers
in the CNS than does the avirulent strain, dsTE12Q, and
induces
more neuronal death but does not elicit a greater detectable
inflammatory
response.
dsTE12H infection increases the expression of more host genes
than does dsTE12Q infection.
To investigate differences in the
host response to infection with the avirulent dsTE12Q strain and
the virulent dsTE12H strain, we performed cDNA microarray analysis
of pooled RNA harvested from mouse brains 3 days after infection
using the Mu6500 GeneChip (Affymetrix), which includes probe
pairs that hybridize with approximately 6,500 different murine
genes. In dsTE12Q-, dsTE12H-, and mock-infected brains,
approximately 25% of the genes were judged to be "present" by
GeneChip software absolute algorithm analysis. The overall number
of host genes that had increased expression was greater in response to
dsTE12H infection than in response to dsTE12Q infection (Fig. 4). Compared to mock-infected
brains, the mRNA expression of 115 genes increased by at least
twofold in dsTE12H-infected brains and the mRNA
expression of only 62 genes increased by at least twofold in
dsTE12Q-infected brains. In contrast, the number of genes with
decreased expression did not significantly differ in dsTE12H-
and dsTE12Q-infected brains (n = 18 and 20, respectively).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Graph showing the distribution of fold changes in gene
expression on comparison of dsTE12H- or dsTE12Q-infected brains
with mock-infected brains. Each category includes all genes that have
at least the fold change indicated on the x axis. NC, no
change. See Materials and Methods for an explanation of the data
analysis.
|
|
dsTE12H infection results in higher levels of expression of
many different cellular genes.
The expression of many cellular
genes increased in both dsTE12H- and dsTE12Q-infected compared
to mock-infected brains (Table 1). The
majority of these genes fell into functional categories that are known
or likely to be important in the host response to viral infections,
including chemokines, extracellular matrix and cell adhesion molecules,
hematopoietic cell surface molecules, and genes involved in antigen
presentation, protein degradation, interferon (IFN)-related, and
complement-related pathways. While many genes had between 2- and
10-fold-increased expression, the expression of a limited number of
genes increased more than 10-fold in dsTE12H-infected brains;
these included chemokine genes (MCP-5 and MCP-1),
complement-related genes (complement component C4 and factor B),
and genes encoding tissue inhibitor of metalloprotease, lymphocyte
antigen LY-6E.1, PBR, cyclophilin C, and interferon response factor
7, and several IFN-inducible genes of unknown function
(GARG-39, IFN-induced 15-kDa protein, IFN-
-induced 11.5-kDa protein, and GARG49).
For about 55% of the genes that were induced in both dsTE12Q- and
dsTE12H-infected brains, the magnitude of increase was at
least
twofold higher in dsTE12H-infected than dsTE12Q-infected
brains. The expression of only two of these genes, encoding MCP-1,
a CC
chemokine, and lipocalin 2 (
44), an acute-phase protein,
increased by more than fivefold between dsTE12H- and
dsTE12Q-infected
brains. The cellular mRNAs whose levels
increased by a greater
magnitude in dsTE12H- than
dsTE12Q-infected brains represent candidate
genes that may play a
role in the host protective or pathologic
response to the more virulent
Sindbis virus infection. There were
no cellular mRNAs whose levels
increased by a greater magnitude
in dsTE12Q- than in
dsTE12H-infected brains and which could be
identified as
candidate host factors that might contribute to
increased host
resistance to the avirulent dsTE12Q
strain.
Some cellular genes have increased expression uniquely in
dsTE12H-infected brains.
To further identify candidate
host genes that may play a role in the host protective or pathologic
response during lethal CNS infection, we identified genes that had
increased expression in dsTE12H-infected brains but not in
dsTE12Q-infected brains (Table 2). In
general, these genes fell into the same functional groups as cellular
mRNAs whose levels were increased in both dsTE12H- and
dsTE12Q-infected brains. However, low levels of increased expression (two- to fourfold range) were seen in unique functional groups of genes including those encoding annexins (e.g., annexin 2, annexin 1, annexin 1 ligand), antiapoptotic Bcl-2 family members (e.g.,
Mcl-1 and Bfl-1), growth arrest/DNA damage-inducible proteins (e.g.,
GADD45
and MyD118), and macrophage inflammatory proteins (MRP14,
MRP8, and chitotriosidase). Of the genes that had increased expression uniquely in dsTE12H-infected brains, the highest
levels of increase were observed for the CC chemokine RANTES and
the regIII-
-proteasome activator (7.5- and 6.4-fold,
respectively, in comparison to dsTE12Q-infected brain).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Genes which are uniquely induced in
dsTE12H-infected brains and which exhibit significant fold
increases compared to their induction in dsTE12Q-infected
brains
|
|
dsTE12Q and dsTE12H infection results in decreased
expression of a limited number of cellular genes.
Compared to the
increases in gene expression observed in dsTE12Q- and
dsTE12H-infected brains, the expression of a smaller number of
host genes decreased in response to Sindbis virus infection and the
magnitude of the decreases tended to be small, ranging mostly between
2- and 3.5-fold (Table 3). This
observation may in part reflect decreases in gene expression occurring
primarily in virally infected neurons (which constitute only a small
subpopulation of the total RNA analyzed), whereas increases in gene
expression probably occur in both infected neurons and other uninfected
cells in the brain. Interestingly, the largest category of genes with decreases in expression encoded proteins that are localized in synaptic
nerve terminals and involved in synaptic function. Decreases in
expression were also observed for other gene categories including those
involved in cholesterol and steroid metabolism, cytoskeletal proteins,
nuclear hormone receptors, neuronal receptors, and signal transduction
molecules.
A subset of genes that are involved in IFN signaling or regulated
by IFNs have increased expression in dsTE12H- and
dsTE12Q-infected brains.
IFN-
/
are known to play a
critical role in defense against Sindbis virus infections
(52; reviewed in reference 21). To help
define the specific molecules that may be important in mediating these
effects, we compared the levels of gene expression in infected brains
of all genes included in the Mu6500 GeneChip that either play a
role in IFN signaling or are known to be induced by IFN
(14) (Fig. 5).
IFN-regulatory factors, especially IRF-1, IRF-3, and IRF-7, are
important transcriptional activators of IFN-
/
gene expression
during viral infections (reviewed in references 45 and
51), and studies with targeted mutant mice have demonstrated a
role for both IRF-1 and IRF-2 in protection against Venezuelan equine
encephalitis virus (20). IRF-1 and IRF-7, but not IRF-2, IRF-3, IRF-4, IRF-5, or IRF-6, gene expression increased in
dsTE12H-infected (8-fold for IRF-1; 25.1-fold for IRF-7) and in
dsTE12Q-infected (4.3-fold for IRF-1; 4.9-fold for IRF-7) brains
compared to mock-infected brains. Stat 1, a signaling molecule that
mediates most biologic responses induced by both IFN-
/
and
IFN-
(reviewed in reference 23), but not Stat 3, 4, 5a,
and 6, also increased in dsTE12H-infected (8.3-fold) and
dsTE12Q-infected (2.6-fold) brains. The expression of IFN-
,
IFN-
, and well-characterized IFN-
/
-inducible, antiviral genes
such as those encoding 2,5-oligoadenylate synthetase,
double-stranded-RNA-activated protein kinase (PKR), and Mx
protein did not change significantly following Sindbis virus
infection. However, a number of other IFN-
/
-inducible genes
(14) with less well-characterized roles in antiviral
defense were induced strongly in dsTE12H-infected brains and to
a lesser extent in dsTE12Q-infected brains, including glucocorticoid-attenuated response genes (GARG-16, GARG-39, and GARG-49) and genes encoding GTP-related proteins (GBP2, GBP3, and
IRG47), a ubiquitin-like molecule (IFN-induced 15-kDa protein), and an
11.5-kDa protein of unknown function.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
mRNA expression of genes involved in IFN signaling
or induced by IFNs in dsTE12H-infected (solid bars) and
dsTE12Q-infected brains (shaded bars). Mock-infected brains were
used as the baseline for comparison analyses.
|
|
A subset of chemokines is induced in dsTE12H-infected and
to a lesser extent in dsTE12Q-infected brains.
Chemokines are
an important functional subgroup of IFN-inducible cytokines that play a
role in both normal CNS development as well as in protective and
pathologic responses during CNS viral infections (reviewed in
references 1 and 6). To investigate which chemokines may
be important in the host response to neurovirulent Sindbis virus
infection, we compared the levels of expression of all known chemokines
included in the Affymetrix 6500 GeneChip (Fig.
6). Small increases in gene expression
were observed in dsTE12H-infected brains for the CXC family
members MIG and Crg-2 but not for other CXC family members such as
KC/GRO1, MIP-2
, LIX, and SDF-1. Among the CC chemokine family
members, the highest levels of increases in expression were observed in
dsTE12H-infected brains for JE/MCP-1, RANTES, MCP-5,
FIC/MCP-3, and MIP-1
. In dsTE12Q-infected brains, smaller
increases were also observed for MCP-1, MCP-3, and MCP-5 but not
for MIP-1
or RANTES. No increases were observed in either
dsTE12H- or dsTE12Q-infected brains for the CC chemokines
MIP-1, MIP-1
, and eotaxin.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
mRNA expression of chemokines in
dsTE12H-infected (solid bars) and dsTE12Q-infected (shaded
bars) brains. Mock-infected brains were used as the baseline for
comparison analyses.
|
|
Potential apoptotic mediators are induced in the brains of Sindbis
virus-infected mice.
Several lines of evidence suggest that
apoptosis plays an important role in the pathogenesis of fatal Sindbis
virus encephalitis (reviewed in reference 36). However,
the specific host molecules that are important in the regulation of
Sindbis virus-induced apoptosis in vivo are unknown. To gain insight
into potential host pathways that may be important in either the
induction or prevention of apoptosis in Sindbis virus-infected brains,
we compared the levels of gene expression of all known and putative
apopototic mediators included on the Mu6500 GeneChip (Fig.
7). Among the Bcl-2 family members, the
only change observed was a minimal increase in the expression of the
antiapoptotic family members bfl-1 and mcl-1 in dsTE12H-infected brains. Among
molecules involved in cell death receptor signaling
pathways, the expression of TNFRp55, but not other molecules, increased
in dsTE12H-infected brains. The physiologic role of this
increase in apoptosis induction in dsTE12H infection is unclear,
since mice lacking TNFRp55 are not protected against disease induced by
dsTE12H (data not shown). The Mu6500 GeneChip contained only
four caspases, C-1, C-2, C-11, and C-14, and of these, only C-11 (a
caspase involved in inflammation but not apoptosis) showed an
increase in the level in dsTE12H-infected compared to
mock-infected brains.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 7.
mRNA expression of pro- and antiapototic genes in
dsTE12H-infected (solid bars) and dsTE12Q-infected (shaded
bars) brains. Mock-infected brains were used as the baseline for
comparison analyses.
|
|
While few significant increases were observed in gene expression
in dsTE12Q-and dsTE12H-infected brains among
well-characterized
apoptotic mediators such as Bcl-2 family
members, cell death receptor-signaling
molecules, and
caspases, there was more marked induction of a
gene encoding PBR, a
mitochondrial protein with putative anti-apoptotic
function. The
expression of PBR increased 10.6-fold in dsTE12H-
and
2.4-fold in dsTE12Q-infected brains. PBR associates with the
voltage-dependent anion channel (VDAC) and the adenine nucleotide
transporter (ANT) in the mitochondrial membrane (
47) and
has
been shown to have antiapoptotic activity in Jurkat cells
(
5).
The expression of another gene encoding a protein
with putative
proapoptotic function, galectin 1, is also mildly
increased in
dsTE12H-infected brains. However, the
proapoptotic activity of
galectin 1 has been found only in T
lymphocytes (reviewed in reference
57), and in peripheral
nerves, galectin 1 promotes axonal regeneration
following axotomy
(
25).
RT-PCR analysis of selected mRNAs and immunohistochemical
analysis of selected proteins in dsTE12H- and
dsTE12Q-infected brains.
To validate our findings
from GeneChip expression analyses, we performed RT-PCR (Fig.
8A) and immunohistochemistry of mouse brain sections (Fig. 8B) to detect the expression of selected representative genes, IRF-7, MCP-1, and PBR, from three major categories (IFN signaling, chemokines, and apoptotic mediators, respectively) that are likely to be important in the host response to
neurovirulent Sindbis virus infection. Increased levels of IRF-7,
MCP-1, and PBR mRNA (but not the constituitively expressed GAPDH
mRNA) were detected by RT-PCR in Sindbis virus-infected compared to
mock-infected brains on days 1, 2, and 3 after infection. In general,
the magnitude of the increases for MCP-1, PBR, and, to a lesser extent,
IRF-7 was proportional to the amount of Sindbis virus RNA. Thus, these
findings confirm that for selected genes, mRNA expression as
measured by RT-PCR analysis of individual mouse brain RNA samples
yields results that are biologically similar to those obtained using
GeneChip expression analysis of pooled RNA samples.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 8.
Expression of IRF-7, MCP-1, and PBR in Sindbis
virus-infected mouse brains. (A) RT-PCR analysis of RNA samples from
triplicate mouse brains harvested at serial time points after infection
with dsTE12H or dsTE12Q or mock infection. H, dsTE12H
infection; Q, dsTE12Q infection; M, mock infection; p.i.,
postinfection. (B) Immunoperoxidase staining demonstrating expression
in a similar brain region of Sindbis virus antigen (left column) and
IRF-7, MCP-1, and PBR in adjacent sections (right column) 3 days after
infection with dsTE12H. Top and middle panels are from the brain
stem: bottom panel is from the posterior neocortex. Magnification,
×776.
|
|
In parallel with the increased mRNA expression, we also found that
there was increased IRF-7, MCP-1, and PBR protein expression
in Sindbis
virus-infected brains. No detectable expression of
these proteins was
observed in mock-infected brains (data not
shown), and the highest
levels of expression were observed in
dsTE12H-infected brains,
specifically in regions of the brain
that also displayed Sindbis virus
antigen immunoreactivity (see
representative photomicrographs in Fig.
8B). Within such regions,
there was expression of IRF-7, MCP-1, and PBR
in cells that morphologically
appeared to be neurons, as well as in
some nonneuronal cells.
These findings demonstrate that at least for
some of the genes
that had increased mRNA expression in
GeneChip studies (Table
1) of Sindbis virus-infected brains, there
is a corresponding
increase in CNS protein
expression.
Neuronal PBR expression exerts a protective effect in Sindbis virus
encephalitis.
Our GeneChip expression analysis identified a
number of host genes that have altered expression in Sindbis
virus-infected brains. Although such genes represent candidate
mediators of CNS viral pathogenesis, the exact significance of
alterations in the expression of given genes is unknown. Given the
importance of neuronal apoptosis in Sindbis virus pathogenesis
(reviewed in reference 36), we tested the hypothesis that
increased expression of PBR, a putative antiapoptotic molecule
(5, 8, 49), represents a protective host response in
Sindbis virus-infected neurons. While dsTE12H but not
dsTE12Q is neurovirulent in 10-day-old mice, both dsTE12H
and dsTE12Q result in 100% mortality in 1-day-old mice. In
contrast to 10-day-old mice, where PBR expression increased in both
dsTE12H- and dsTE12Q-infected brains, we found that no PBR
expression was detected by RT-PCR analysis (data not shown) or
immunohistochemistry (Fig. 9) in
the brains of 1-day-old mice infected with either
dsTE12H or dsTE12Q. Therefore, we used the Sindbis virus vector
system to evaluate whether the expression of PBR in neurons of Sindbis
virus-infected 1-day-old mice (which do not normally upregulate PBR
expression in response to Sindbis virus infection) would
alter the natural history of fatal Sindbis virus encephalitis. We
cloned flag epitope-tagged PBR and a control construct of PBR
lacking the start codon into dsTE12Q to generate the
recombinant chimeric viruses, dsTE12Q/PBR and
dsTE12Q/PBRcontrol.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 9.
PBR induction in apoptotic areas of 10-day-old mouse
brain but not 1-day-old mouse brain infected with Sindbis virus.
Adjacent mouse brain sections were stained to detect Sindbis virus
antigen, TUNEL-positive nuclei, or PBR expression 3 days after
infection. Shown are representative sections that include regions of
the colliculus and cerebellum. Arrows denote specific regions of each
section that demonstrate both viral antigen staining and TUNEL-positive
nuclei. Magnification, ×85.
|
|
Following dsTE12Q/PBR infection, flag-PBR could be detected in
regions of the brain that demonstrated Sindbis virus immunoreactivity
(data not shown). Infection with 1,000 PFU of dsTE12Q/PBRcontrol
resulted in 100% mortality, whereas 51% of mice infected with
dsTE12Q/PBR survived (Fig.
10A). (A
similar survival rate was also
observed following infection with
a chimeric virus expressing
PBR lacking a flag epitope [data not
shown].) Viral replication
as measured by plaque assay titer
determination did not differ
significantly in the brains of
dsTE12Q/PBR- and dsTE12Q/PBRcontrol-infected
mice, except that
the brains of dsTE12Q/PBR-infected mice had
slightly higher mean
viral titers on day 2 after infection (Fig.
10B). However, on both days
2 and 3 after infection, the brains
of dsTE12Q/PBR-infected mice
had significantly fewer cells that
demonstrated TUNEL positivity
(Fig.
10C). Thus, neuronal PBR expression
in virally infected
neurons can decrease neuronal apoptosis and
protect 1-day-old mice
against fatal disease without inhibiting
viral replication.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 10.
Enforced PBR expression protects neonatal mice against
lethal Sindbis virus infection. (A) Survival curves of 1-day-old mice
infected intracerebrally with 1,000 PFU of dsTE12Q/PBR or
dsTE12Q/PBRcontrol. The results represent combined survival curves
for five independent litters with 10 to 12 mice per litter. (B) Viral
growth in mouse brains infected with dsTE12Q/PBR or
dsTE12Q/PBRcontrol. Each data point represents the mean and
standard error of the mean for three mouse brains. (C) Quantitation of
apoptotic cells in mouse brains infected with dsTE12Q/PBR or
dsTE12Q/PBRcontrol. Each data point represents the mean and
standard error of the mean for sagittal sections from three to five
different mouse brains. Quantitation was performed as described in
Materials and Methods.
|
|
 |
DISCUSSION |
In this study, we compared the CNS gene expression
profiles in 10-day-old mice infected intracerebrally with two strains
of Sindbis virus, dsTE12Q and dsTE12H, that are closely related
genetically but differ dramatically in neurovirulence. dsTE12Q
contains a wild-type glutamine at E2-55, replicates to lower titers in
mouse brain, results in less neuronal death, and produces no clinically apparent disease, whereas dsTE12H contains a neurovirulent
histidine substition at E2-55, replicates to higher titers in mouse
brain, results in more neuronal death, and invariably produces fatal disease. In parallel with the increased neurovirulence of dsTE12H, the increases in host gene expression were more marked in
dsTE12H-infected brains. The expression levels of more cellular
mRNAs were increased in dsTE12H-infected compared to
dsTE12Q-infected brains, and for cellular mRNAs that had
increased levels in both dsTE12H- and dsTE12Q-infected
brains, the magnitude of increase was usually greater in
dsTE12H-infected brains. This increased host gene expression in
mice infected with a more neurovirulent strain may play a role in both
increased antiviral defense and increased virus-induced injury in the brain.
Our results identify several host genes with altered CNS expression
that may be involved in the host response to Sindbis virus infection.
The majority of these genes can be classified into functional groups
that are already known to be involved in the host response to infection
with Sindbis virus and other neurotropic viruses, including genes
encoding antigen presentation molecules, immune cell activation
markers, chemokines, and IFN-inducible gene products. The
identification of specific genes within each of these functional groups
that have increased expression in Sindbis virus-infected brains may
help elucidate the molecular details of important host response
pathways. For example, the expression levels of two CC chemokines,
RANTES and MCP-1, which have both neuroprotective and
proinflammatory effects in the CNS, both increased significantly in
dsTE12H-infected compared to in dsTE12Q-infected brains, and these two chemokines represent candidate regulators of
Sindbis virus neuropathogenesis. RANTES and MCP-1 are upregulated in several other CNS viral infections (2, 11, 12, 33, 34, 46, 53,
54), including in genetically susceptible but not genetically
resistant strains of mice infected with mouse adenovirus type 1 (10). The selective increase in the level of RANTES in
dsTE12H- but not in dsTE12Q-infected brains is interesting since RANTES has been directly implicated in the pathogenesis of
mouse hepatitis virus-induced demyelination (34). The
upregulation of MCP-1 is also noteworthy in light of recent findings by
Gil et al. (18a). They demonstrated that IFN-
/
/
receptor-deficient mice were much more susceptible than Stat1-deficient
mice to Sindbis virus infection and that MCP-1 was one of the few genes
that is induced by IFN in a Stat-1-independent manner. This suggests
that MCP-1 may be an IFN-regulated gene that is important in protection against Sindbis virus infection.
Surprisingly, no increases were observed in IFN-
or IFN-
in
brains infected with either dsTE12H or dsTE12Q, despite
induction of IFN-
/
transcriptional activators (e.g., IRF-1 and
IRF-7), IFN-
/
signaling molecules (e.g., Stat1), and a number of
known IFN-
/
-inducible genes (see above). This may reflect the
lower sensitivity of the GeneChip analysis compared to bioassays
previously used to measure induction of IFN-
/
activity in Sindbis
virus-infected brains (56, 61). Alternatively, since IFN
production is an early response in CNS Sindbis virus infections, our
microarray analysis may have been performed at a time point that was
too late to detect increases in IFN-
or IFN-
mRNA levels.
These considerations raise the possibility that IFNs and other
important genes that have increased expression in Sindbis
virus-infected brains may have been missed in our screen, either due to
the intrinsic sensitivity of the GeneChip assay or to the kinetics
of host gene expression. Despite these limitations, the specific
IFN pathway-related genes that are increased in Sindbis virus-infected
brains represent potential mediators of the IFN-
/
antiviral host
response to Sindbis virus infection.
The increased expression of one class of inflammatory genes,
complement-related proteins, was a somewhat unexpected finding in our
study. Complement-related proteins are upregulated in brain microglia
in response to cerebral ischemia (55), and
complement-mediated lysis has been postulated to play a role in
neurodegenerative diseases (16). However, despite the
importance of complement as part of the innate immune response to
microbial invasion, very little attention has been devoted in the past
two decades to the role of complement in CNS viral infections. In
addition, there are no previous reports of altered gene expression of
complement proteins within the brain during viral infection.
However, Hirsch et al. found that Sindbis virus-infected mice
treated with cobra venom factor to deplete the third component of
complement had 1,000-fold-greater viral titers in the brain
(25). Although the mechanism was postulated to reflect
systemic effects of complement on viral replication in the bloodstream
(26), our observation that expression of complement genes
increases in Sindbis virus-infected mouse brains raises the possibility
that complement may also play a more direct role in antiviral responses
in the CNS.
It is also interesting that the marked increases in the expression of
inflammatory response genes in 10-day-old Sindbis virus-infected mouse
brains were observed in the absence of histologic evidence of frank
"encephalitis" (i.e., brain inflammation). Similar increases in
chemokine gene expression in the absence of inflammation have also been
found in neonatal rodents infected with Borna disease virus
(54). Although we cannot rule out the possibility that some of the changes in inflammatory gene expression reflect
infiltrating inflammatory cells that we failed to detect on H & E
analysis of mouse brain sections, most of the alterations in
inflammatory gene expression are probably occurring within intrinsic
brain cells. This hypothesis is consistent with increasing evidence demonstrating that different types of brain cells, including neurons, microglia, and astrocytes, are capable of producing cytokines, chemokines, and other immunomoregulatory molecules (reviewed in reference 6). In support of our hypothesis, we found that
expression of IRF-7 and the CC chemokine MCP-1 were detected in the
same regions of the brain and in the same cell types which expressed Sindbis virus antigen (i.e., neurons). Similarly, Wesselingh et al.
reported production of numerous cytokines by intrinsic brain cells in
scid mice infected with Sindbis virus (62).
Given the important effects of immune mediators in the CNS
(neuroprotective as well as neurotoxic), the host gene response profile
in a CNS infection may be a more accurate reflection of
pathogenetically relevant "inflammation" than traditional
histologic criteria.
In addition to identifying specific candidate host response genes
within functional groups that are already known to be important in CNS
viral infections, our findings identify novel groups of genes that are
not yet known to play a role in the host response to Sindbis virus
infection. We observed significant increases in the expression of
several host genes involved in protein degradation, particularly in the
brains of mice infected with the more neurovirulent strain of Sindbis
virus, dsTE12H. Although some of these genes such as the
proteasomal components are involved in antigen processing, the
upregulated expression of genes involved in lysosomal,
ubiquitin-mediated, and other forms of proteolysis could have
additional, as yet undefined effects on the pathogenesis of CNS viral
infections. For example, a role for upregulation of the gene encoding
lysosomal M (the protein degradation gene with the greatest increase in
expression in dsTE12H-infected brains) has been postulated to
play a role in microglia-induced neurotoxic injury and the generation
of spongiform changes in the brains of mice affected with an
experimental prion disease (32). We also observed
decreases in expression of several host genes encoding proteins that
localize to synaptic nerve terminals and are involved in synaptic
function (e.g., endophilin,
-SNAP, ankyrin G, complexin II, and heat
shock cognate protein 70), although these decreases were modest and it
is difficult to speculate on their biological significance.
Nonetheless, in view of previous reports that lymphocytic
choriomeningitis virus selectively decreases the transcription of a
neuronal gene, GAP-43, involved in synaptic plasticity (7,
13) and that Borna disease virus selectively depresses certain
neurotransmitter mRNA levels (42, 43), the decreased
expression of these genes in Sindbis virus-infected brains may be of
potential relevance to understanding the effects of Sindbis virus
infection on neuronal function.
While our findings identify candidate regulators of Sindbis virus
neuropathogenesis, the significance of alterations in expression of
individual genes is unclear without further investigation, including
direct tests of gene function in vivo. First, it is possible that the
GeneChip assay produced "false-positive" results. Our RT-PCR
and immunohistochemical analyses of IRF-7, MCP-1, and PBR expression
provide confirmation of our GeneChip findings by independent
methods and argue against this possibility. In addition, we have
performed RNase protection assays to detect apoptotic regulatory gene
expression in dsTE12Q- and dsTE12H-infected brains from
10-day-old mice and our results are consistent with the findings of our GeneChip analysis; there is increased expression of
bfl-1 mRNA (but not other bcl-2 family
members) and of TNFRp55 mRNA (C. Johnston and B. Levine,
unpublished data). Second, a more major limitation is that one cannot
ascertain from data related to the expression level of a gene whether
the gene plays a role in viral pathogenesis. For example, higher levels
of expression of any individual gene in dsTE12H-infected
compared to mock- or dsTE12Q-infected brains could (i) be involved
in the increased neuropathology of dsTE12H infection, (ii)
represent a more vigorous host protective response induced by higher
levels of viral replication, or (iii) have no beneficial or detrimental
role in dsTE12H pathogenesis.
To address this latter limitation, we chose to use the Sindbis virus
vector system as a functional screen to evaluate a novel candidate
regulator of pathogenesis, PBR, which was identified in our
GeneChip expression analysis. We selected PBR for further analysis
based on several considerations. First, cellular mRNA levels were
higher in dsTE12H- than in dsTE12Q-infected brains, raising
the possibility that PBR upregulation might either play a role in
neuropathology or represent a more vigorous host antiviral response
induced by higher levels of viral replication. Second, our
immunohistochemical staining confirmed that PBR protein expression was
upregulated in virally infected apoptotic neuronal foci in the brains
of 10-day-old dsTE12H-infected mice. This enabled us to examine
the effects of enforced neuronal PBR expression by a recombinant
chimeric Sindbis virus in 1-day-old mice that lack detectable increases
in endogenous PBR following Sindbis virus infection. Third, PBR was of
particular interest because it is a potentially novel mitochondrial
regulator of apoptosis and Sindbis virus-induced apoptosis plays an
important role in CNS viral pathogenesis. Therefore, we hypothesized
that upregulation of PBR in virally infected neurons may be a host
defense mechanism designed to block Sindbis virus-induced apoptosis.
Our findings demonstrate that enforced neuronal PBR expression protects
1-day-old mice against lethal Sindbis virus encephalitis and decreases
the number of apoptotic cells in Sindbis virus-infected brains. To our
knowledge, our microarray analysis results represent the first
demonstration of upregulation of PBR in a viral infection and our
studies with the Sindbis virus vector system represent the first
demonstration of a protective role for PBR upregulation in CNS disease.
PBR expression has been reported to increase in the brain in response
to a variety of other, nonviral, neurotoxic insults including
excitotoxic injury, ischemia, and chemical sympathetectomy, although in
most studies, the increased expression was thought to be in reactive
glial cells (reviewed in references 4 and 17). However,
PBR is thought to mediate the electrophysiological actions of a PBR
agonist on cerebellar Purkinje neurons (3), indicating a
functional role for PBR in at least some neuronal populations. The
significance of upregulation of PBR expression in CNS injury has been
unclear, but increased PBR expression has been postulated to play a
role in protecting human hematopoietic cells against oxygen radical
damage (8), rat corpora lutea against gonadotropin
releasing hormone-induced apoptosis (49), and
human epidermal cells against free radical damage from UV exposure
(58). The mechanism of protective action of upregulated PBR expression is postulated to involve an increase in the level of
mitochondrial membrane cholesterol, which prevents the release of
cytochrome c through the mitochondrial permeability membrane transition pore.
The results of our study suggest that the upregulation of PBR may be an
important host protective response against Sindbis virus infection, as
well as other CNS insults. The apparent failure of 1-day-old mice to
increase PBR expression following Sindbis virus infection may
contribute to their increased susceptibility to fatal disease, and CNS
developmental changes in PBR upregulation may contribute to the
resistance of older mice to Sindbis virus-induced neuronal injury. The
ability of enforced neuronal expression of PBR, a mitochondrial
membrane protein that associates with VDAC and ANT, to reduce
the number of apoptotic neurons in Sindbis virus-infected brains
suggests that Sindbis virus-induced neuronal apoptosis may be triggered
through a mitochondrial pathway. This hypothesis is consistent with the
findings of Jan et al. (28) indicating that Sindbis
virus-induced apoptosis in neuroblastoma cells involves the release of
ceramide, a known inducer of mitochondrial cytochrome c
(reviewed in reference 19). Regardless of the
mechanism by which PBR exerts its neuroprotective actions, our findings raise the possibility that modulation of this receptor by the administration of previously characterized, selective
pharmacologist PBR agonists (reviewed in references 4 and
17) may be beneficial in the treatment of CNS viral diseases.
The identification of PBR as a novel molecule involved in the host
protective response to Sindbis virus infection illustrates the
potential utility of combining microarray analysis with functional screens to study host genes that regulate viral pathogenesis. Further
analysis of additional host genes that were found to have increased
expression in Sindbis virus-infected brains will likely yield new
insights into the role of specific host responses in CNS alphavirus pathogenesis.
 |
ACKNOWLEDGMENTS |
We thank the Microarray Facility of the Albert Einstein College
of Medicine for assistance in performing Affymetrix GeneChip expression analysis and James Goldman and Carol Troy for assistance in
performing neuropathology analysis.
This work was supported by NIH grants R29A140246 and RO1 AI44157 and an
Irma T. Hirschl Trust Scholar Award to B.L.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, Columbia University College of Physicians & Surgeons, 630 W. 168th St., New York, NY 10032. Phone: (212) 305-7312. Fax: (212) 305-7290. E-mail: levine{at}cuccfa.ccc.columbia.edu.
Present address: Department of Biochemistry and Molecular Biology,
Mount Sinai School of Medicine, New York, NY 10029.
 |
REFERENCES |
| 1.
|
Ascensio, V. C., and I. L. Campbell.
1999.
Chemokines in the CNS: plurifunctional mediators in diverse states.
Trends Neurosci.
22:504-512[CrossRef][Medline].
|
| 2.
|
Asensio, V. C., and I. L. Campbell.
1997.
Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.
J. Virol.
71:7832-7840[Abstract].
|
| 3.
|
Basile, A. S.,
G. T. Bolger,
H. W. Lueddens, and P. Skolnick.
1989.
Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
J. Pharmacol. Exp. Ther.
248:463-469[Abstract/Free Full Text].
|
| 4.
|
Beurdeley-Thoma, A.,
L. Miccoli,
S. Oudard,
B. Dutrillaux, and M. F. Poupon.
2000.
The peripheral benzodiazepine receptors: a review.
J. Neuro-Oncol.
46:45-56[CrossRef][Medline].
|
| 5.
|
Bono, F.,
I. Lamarche,
V. Prabonnaud,
G. LeFur, and J. M. Herbert.
1999.
Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities.
Biochem. Biophys. Res. Commun.
265:457-461[CrossRef][Medline].
|
| 6.
|
Campbell, I. L.
2000.
Cytokines and chemokines in defense and damage in the intact CNS.
In
P. K. Peterson, and J. S. Remington (ed.), New concepts in the immunopathogenesis of CNS infections. Blackwell Science, Oxford, United Kingdom.
|
| 7.
|
Cao, W.,
M. B. Oldstone, and J. C. de la Torre.
1997.
Viral persistent infection affects both transcriptional and posttranscriptional regulation of neuron-specific molecule GAP43.
Virology
230:147-154[CrossRef][Medline].
|
| 8.
|
Carayon, P.,
M. Portier,
D. Dussossoy,
A. Bord,
G. Petitpretre,
X. Canat,
G. LeFur, and P. Casellas.
1996.
Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage.
Blood
87:3170-3178[Abstract/Free Full Text].
|
| 9.
|
Chang, Y. E., and L. A. Laimans.
2000.
Microarray analysis identified interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.
J. Virol.
74:4174-4182[Abstract/Free Full Text].
|
| 10.
|
Charles, P. C.,
X. Chen,
M. S. Horwitz, and C. F. Brosnan.
1999.
Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice.
J. Neurovirol.
5:55-64[Medline].
|
| 11.
|
Chen, C. J.,
S. L. Liao,
M. D. Kuo, and Y. M. Wang.
2000.
Astrocytic alteration induced by Japanese encephalitis virus infection.
Neuroreport
11:1933-1937[Medline].
|
| 12.
|
Conant, K.,
A. Garzino,
A. Nath,
J. C. McArthur,
W. Halliday,
C. Power,
R. C. Gallo, and E. O. Major.
1998.
Induction of monocyte chemoattract protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
Proc. Natl. Acad. Sci. USA
95:3117-3121[Abstract/Free Full Text].
|
| 13.
|
de la Torre, J. C.,
M. Mallory,
M. Brot,
L. Gold,
G. Koob,
M. B. Oldstone, and E. Masliah.
1996.
Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells.
Virology
220:508-515[CrossRef][Medline].
|
| 14.
|
Der, S. D.,
A. Zhou,
B. R. G. Williams, and R. H. Silverman.
1998.
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
Proc. Natl. Acad. Sci. USA
95:15623-15628[Abstract/Free Full Text].
|
| 15.
|
Derocg, J.-M.,
O. Jbilo,
M. Bouaboula,
M. Sequi,
C. Clere, and P. Casellas.
2000.
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60.
J. Biol. Chem.
275:15621-15628[Abstract/Free Full Text].
|
| 16.
|
Gasque, P.,
Y. D. Dean,
E. P. McGreal,
J. VanBeek, and B. P. Morgan.
2000.
Complement components of the immune system in health and disease in the CNS.
Immunopharmacology
49:171-186[CrossRef][Medline].
|
| 17.
|
Gavish, M.,
I. Bachman,
R. Shoukrun,
Y. Katz,
L. Veenman,
G. Weisinger, and A. Weizman.
1991.
Enigma of the peripheral denzodiazepine receptor.
Pharmacol. Rev.
51:629-650[Abstract/Free Full Text].
|
| 18.
|
Geiss, G. K.,
R. E. Bumgarner,
M. C. An,
M. B. Agy,
A. B. van ter Wout,
E. Hammersmark,
V. S. Carter,
D. Upchurch,
J. I. Mullins, and M. G. Katze.
2000.
Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.
Virology
266:8-16[CrossRef][Medline].
|
| 18a.
|
Gil, M. L.,
E. Bohn,
A. K. O'Guin,
C. V. Ramana,
B. Levine,
G. R. Stark,
H. W. Virgin, and R. D. Schreiber.
2001.
Biological consequences of Stat1-independent IFN signaling.
Proc. Natl. Acad. Sci. USA
98:6680-6685[Abstract/Free Full Text].
|
| 19.
|
Green, D., and J. Reed.
1998.
Mitochondria and apoptosis.
Science
281:1309-1312[Abstract/Free Full Text].
|
| 20.
|
Grieder, F. B., and S. N. Vogel.
1999.
Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Virology
257:106-118[CrossRef][Medline].
|
| 21.
|
Griffin, D. E.
1986.
Alphavirus pathogenesis and immunity, p. 209-236.
In
S. Schlesinger, and M. J. Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum Press, New York, N.Y.
|
| 22.
|
Griffin, D. E.
1989.
Molecular pathogenesis of Sindbis virus encephalitis in experimental animals.
Adv. Virus Res.
36:255-271[Medline].
|
| 23.
|
Hague, S. J., and B. R. Williams.
1998.
Signal transduction in the interferon system.
Semin. Oncol.
25:14-22[Medline].
|
| 24.
|
Hardwick, J. M., and B. Levine.
2000.
Sindbis virus vector system for functional analysis of apoptosis regulators.
Methods Enzymol.
322:492-508[Medline].
|
| 25.
|
Hirsch, R. L.,
D. E. Griffin, and J. A. Winkelstein.
1978.
The effect of complement depletion on the course of Sindbis virus infection in mice.
J. Immunol.
121:1276-1278[Abstract/Free Full Text].
|
| 26.
|
Hirsch, R. L.,
D. E. Griffin, and J. A. Winkelstein.
1980.
The role of complement in viral infections. II. The clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement.
J. Infect. Dis.
141:212-217[Medline].
|
| 27.
|
Horie, H.,
Y. Inagaki,
Y. Sohma,
R. Nozaw,
K. Okawa,
M. Hasegawa,
N. Muramatsu,
H. Kawano,
M. Horie,
H. Koyama,
I. Sakai,
K. Takeshita,
Y. Kowada,
M. Takano, and T. Kadova.
1999.
Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy.
J. Neurosci.
19:9964-9974[Abstract/Free Full Text].
|
| 28.
|
Jan, J.-T.,
S. Chatterjee, and D. Griffin.
2000.
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide.
J. Virol.
74:6425-6432[Abstract/Free Full Text].
|
| 29.
|
Joe, A.,
G. Ferrari,
H. Jiang, and B. Levine.
1996.
Dominant inhibitory Ras expression delays Sindbis virus-induced apoptosis in neuronal cells.
J. Virol.
68:7744-7751.
|
| 30.
|
Johnson, R. T., and H. F. McFarland.
1972.
Age-dependent resistance to viral encephalitis: sutides of infections due to Sindbis virus in mice.
J. Infect. Dis.
125:257-262[Medline].
|
| 31.
|
Kerr, D. A.,
J. P. Nery,
R. T. Traystman,
B. N. Chau, and J. M. Hardwick.
2000.
Survival motor neuron protein modulates neuron-specific apoptosis.
Proc. Natl. Acad. Sci. USA
97:13312-13317[Abstract/Free Full Text].
|
| 32.
|
Kopacek, J.,
S. Sakaguchi,
K. Shigematsu,
N. Nishida,
R. Atarashi,
R. Nakaoke,
R. Moriuchi,
M. Niwa, and S. Katamine.
2000.
Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease.
J. Virol.
74:411-417[Abstract/Free Full Text].
|
| 33.
|
Lane, T. E.,
V. C. Asensio,
N. Yu,
A. D. Paoletti,
I. L. Campbell, and M. J. Buchmeier.
1998.
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyclinating disease.
J. Immunol.
160:970-978[Abstract/Free Full Text].
|
| 34.
|
Lane, T. E.,
M. T. Lieu,
B. P. Chen,
V. C. Asensio,
R. M. Samawi,
A. D. Paoletti,
I. L. Campbell,
S. L. Kunkel,
H. S. Fox, and M. J. Buchmeier.
2000.
A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination.
J. Virol.
74:1415-1424[Abstract/Free Full Text].
|
| 35.
|
Lee, C.-K.,
R. G. Klopp,
R. Weinruch, and T. A. Prolla.
1999.
Gene expression profile of aging and its retardation by caloric restriction.
Science
285:1390-1393[Abstract/Free Full Text].
|
| 36.
| Levine, B. Apoptosis in viral infections of
neurons: a protective or pathologic host response? Curr. Top.
Microbiol. Immunol., in press.
|
| 37.
|
Levine, B.,
J. E. Goldman,
H. H. Jiang,
D. E. Griffin, and J. M. Hardwick.
1996.
Bcl-2 protects mice against fatal alphavirus encephalitis.
Proc. Natl. Acad. Sci. USA
93:4810-4815[Abstract/Free Full Text].
|
| 38.
|
Levine, B., and D. E. Griffin.
1993.
Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice.
J. Virol.
67:6872-6875[Abstract/Free Full Text].
|
| 39.
|
Lewis, J.,
G. Oyler,
K. Ueno,
Y. Fannjiang,
B. Chau,
J. Vornov,
S. Korsmeyer,
S. Zou, and J. Hardwick.
1999.
Inhibition of virus-induced neuronal apoptosis by Bax.
Nat. Med.
5:832-835[CrossRef][Medline].
|
| 40.
|
Lewis, J.,
S. L. Wesslingh,
D. E. Griffin, and J. M. Hardwick.
1996.
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence.
J. Virol.
70:1828-1835[Abstract].
|
| 41.
|
Liang, X. H.,
L. Kleeman,
H. H. Jiang,
G. Gordon,
J. E. Goldman,
G. Berry,
B. Herman, and B. Levine.
1998.
Protection against fatal Sindbis virus encephalitis by Beclin, a novel Bcl-2 interacting protein.
J. Virol.
72:8586-8596[Abstract/Free Full Text].
|
| 42.
|
Lipkin, W. I.,
E. L. Battenberg,
F. E. Bloom, and M. B. Oldstone.
1988.
Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury.
Brain Res.
451:333-339[CrossRef][Medline].
|
| 43.
|
Lipkin, W. I.,
K. M. Carbone,
M. C. Wilson,
C. S. Duchala,
O. Narayan, and M. B. Oldstone.
1988.
Neurotransmitter abnormalities in Borna disease.
Brain Res.
475:366-370[CrossRef][Medline].
|
| 44.
|
Liu, Q., and M. Nilsen-Hamiliton.
1995.
Identification of a new acute phase protein.
J. Biol. Chem.
70:22565-22570.
|
| 45.
|
Mamane, Y.,
C. Heylbroeck,
P. Genin,
M. Algarte,
M. J. Servant,
C. LePage,
C. DeLuca,
H. Kwon,
R. Lin, and J. Hiscott.
1999.
Interferon regulatory factors: the next generation.
Gene
237:1-14[CrossRef][Medline].
|
| 46.
|
Manchester, M.,
D. Eto, and M. Oldstone.
1999.
Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice.
J. Neuroimmunol.
96:207-217[CrossRef][Medline].
|
| 47.
|
McEnery, M. W.,
A. M. Snowman,
R. R. Trifiletti, and S. H. Snyder.
1992.
Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier.
Proc. Natl. Acad. Sci. USA
89:3170-3174[Abstract/Free Full Text].
|
| 48.
|
Mossman, K. L.,
P. F. Macgregor,
J. J. Rozmus,
A. B. Goryachev,
A. M. Edwards, and J. M. Smiley.
2001.
Herpes simplex virus triggers and then disarms a host antiviral response.
J. Virol.
75:750-758[Abstract/Free Full Text].
|
| 49.
|
Papadopoulos, V.,
A. M. Dharmarajan,
H. Li,
M. Culty,
M. Lemay, and R. Sridaran.
1999.
Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum.
Biochem. Pharmacol.
58:1389-1393[CrossRef][Medline].
|
| 50.
|
Peterson, P. K., and J. S. Remington (ed.).
2000.
New concepts in the immunopathogenesis of CNS infections.
Blackwell Science, Inc., Malden, Mass.
|
| 51.
|
Pitha, P. M.,
W. C. Au,
W. Lowther,
Y. T. Juang,
S. L. Schafer,
L. Burysek,
J. Hiscott, and P. A. Moore.
1998.
Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth.
Biochemie
80:651-658[Medline].
|
| 52.
|
Ryman, K. D.,
W. B. Klimstra,
H. B. Nguyen,
C. A. Biron, and R. E. Johnston.
2000.
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.
J. Virol.
74:3366-3378[Abstract/Free Full Text].
|
| 53.
|
Sasseville, V. G.,
M. M. Smith,
C. R. Mackay,
D. R. Pauley,
K. G. Mansfield,
D. J. Ringler, and A. A. Lackner.
1996.
Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.
Am. J. Pathol.
149:1459-1467[Abstract].
|
| 54.
|
Sauder, C.,
W. Hallensleben,
A. Pagenstecher,
S. Schneckenburger,
L. Biro,
D. Pertlik,
J. Hausmann,
M. Suter, and P. Staeheli.
2000.
Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation.
J. Virol.
74:9267-9280[Abstract/Free Full Text].
|
| 55.
|
Schafer, M. K.,
W. J. Schwaeble,
C. Post,
P. Salvati,
M. Calabresi,
R. B. Sim,
F. Petry,
M. Loos, and E. Weihe.
2000.
Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia.
J. Immunol.
164:5446-5452[Abstract/Free Full Text].
|
| 56.
|
Sherman, L. A., and D. E. Griffin.
1990.
Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus.
J. Virol.
64:2041-2046[Abstract/Free Full Text].
|
| 57.
|
Sotomayor, C. E., and G. A. Rabinovich.
2000.
Galectin-1 induces central and peripheral death: implications in T-cell physiology.
Dev. Immunol.
7:117-129[Medline].
|
| 58.
|
Stoebner, P. E.,
P. Carayon,
G. Penarier,
N. Frechin,
G. Barneon,
P. Casellas,
J. P. Cano,
J. Meynadier, and L. Meunier.
1999.
The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation.
Br. J. Dermatol.
140:1010-1016[CrossRef][Medline].
|
| 59.
|
Tucker, P. C.,
E. G. Strauss,
R. J. Kuhn,
J. H. Strauss, and D. E. Griffin.
1993.
Viral determinants of age-dependent virulence of Sindbis virus for mice.
J. Virol.
67:4605-4610[Abstract/Free Full Text].
|
| 60.
|
Ubol, S.,
P. Tucker,
D. Griffin, and J. Hardwick.
1994.
Neurovirulent strains of alphavirus induce apoptosis in bcl 2-expressing cells: role of a single amino acid change in the E2 glycoprotein.
Proc. Natl. Acad. Sci. USA
91:5202-5206[Abstract/Free Full Text].
|
| 61.
|
Vilcek, J.
1964.
Production of interferon by newborn and adult mice infected with Sindbis virus.
Virology
22:651-652.
|
| 62.
|
Wesselingh, S. L.,
B. Levine,
R. J. Fox,
S. Choi, and D. E. Griffin.
1994.
Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response.
J. Immunol.
152:1289-1297[Abstract].
|
| 63.
|
Wodicka, L.,
H. Dong,
M. Mittmann,
M. H. Ho, and D. J. Lockhart.
1997.
Genome-wide expression monitoring in Saccharomyces cerevisiae.
Nat. Biotechnol.
15:1359-1367[CrossRef][Medline].
|
| 64.
|
Zhu, H.,
J.-P. Cong,
G. Mamtora,
T. Gineras, and T. Shenk.
1998.
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.
Proc. Natl. Acad. Sci. USA
95:14470-14475[Abstract/Free Full Text].
|
Journal of Virology, November 2001, p. 10431-10445, Vol. 75, No. 21
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.21.10431-10445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Clarke, P., Beckham, J. D., Leser, J. S., Hoyt, C. C., Tyler, K. L.
(2009). Fas-Mediated Apoptotic Signaling in the Mouse Brain following Reovirus Infection. J. Virol.
83: 6161-6170
[Abstract]
[Full Text]
-
Do Carmo, S., Jacomy, H., Talbot, P. J., Rassart, E.
(2008). Neuroprotective Effect of Apolipoprotein D against Human Coronavirus OC43-Induced Encephalitis in Mice. J. Neurosci.
28: 10330-10338
[Abstract]
[Full Text]
-
Venneti, S., Bonneh-Barkay, D., Lopresti, B. J., Bissel, S. J., Wang, G., Mathis, C. A., Piatak, M. Jr., Lifson, J. D., Nyaundi, J. O., Murphey-Corb, M., Wiley, C. A.
(2008). Longitudinal in Vivo Positron Emission Tomography Imaging of Infected and Activated Brain Macrophages in a Macaque Model of Human Immunodeficiency Virus Encephalitis Correlates with Central and Peripheral Markers of Encephalitis and Areas of Synaptic Degeneration. Am. J. Pathol.
172: 1603-1616
[Abstract]
[Full Text]
-
Ryman, K. D., Gardner, C. L., Meier, K. C., Biron, C. A., Johnston, R. E., Klimstra, W. B.
(2007). Early restriction of alphavirus replication and dissemination contributes to age-dependent attenuation of systemic hyperinflammatory disease. J. Gen. Virol.
88: 518-529
[Abstract]
[Full Text]
-
Wacher, C., Muller, M., Hofer, M. J., Getts, D. R., Zabaras, R., Ousman, S. S., Terenzi, F., Sen, G. C., King, N. J. C., Campbell, I. L.
(2007). Coordinated Regulation and Widespread Cellular Expression of Interferon-Stimulated Genes (ISG) ISG-49, ISG-54, and ISG-56 in the Central Nervous System after Infection with Distinct Viruses. J. Virol.
81: 860-871
[Abstract]
[Full Text]
-
Saha, S., Sugumar, P., Bhandari, P., Rangarajan, P. N.
(2006). Identification of Japanese encephalitis virus-inducible genes in mouse brain and characterization of GARG39/IFIT2 as a microtubule-associated protein.. J. Gen. Virol.
87: 3285-3289
[Abstract]
[Full Text]
-
Kunz, S., Rojek, J. M., Roberts, A. J., McGavern, D. B., Oldstone, M. B. A., de la Torre, J. C.
(2006). Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.. J. Virol.
80: 9082-9092
[Abstract]
[Full Text]
-
Saha, S., Murthy, S., Rangarajan, P. N.
(2006). Identification and characterization of a virus-inducible non-coding RNA in mouse brain. J. Gen. Virol.
87: 1991-1995
[Abstract]
[Full Text]
-
Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B., Virgin, H. W. IV
(2005). Identification of Interferon-Stimulated Gene 15 as an Antiviral Molecule during Sindbis Virus Infection In Vivo. J. Virol.
79: 13974-13983
[Abstract]
[Full Text]
-
Prehaud, C., Megret, F., Lafage, M., Lafon, M.
(2005). Virus Infection Switches TLR-3-Positive Human Neurons To Become Strong Producers of Beta Interferon. J. Virol.
79: 12893-12904
[Abstract]
[Full Text]
-
Wang, J., Campbell, I. L.
(2005). Innate STAT1-Dependent Genomic Response of Neurons to the Antiviral Cytokine Alpha Interferon. J. Virol.
79: 8295-8302
[Abstract]
[Full Text]
-
DeBiasi, R. L., Clarke, P., Meintzer, S., Jotte, R., Kleinschmidt-Demasters, B. K., Johnson, G. L., Tyler, K. L.
(2003). Reovirus-Induced Alteration in Expression of Apoptosis and DNA Repair Genes with Potential Roles in Viral Pathogenesis. J. Virol.
77: 8934-8947
[Abstract]
[Full Text]
-
Saha, S., Rangarajan, P. N.
(2003). Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J. Gen. Virol.
84: 1729-1735
[Abstract]
[Full Text]
-
Baker, C. A., Manuelidis, L.
(2003). Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA
100: 675-679
[Abstract]
[Full Text]
-
Everett, H., Barry, M., Sun, X., Lee, S. F., Frantz, C., Berthiaume, L. G., McFadden, G., Bleackley, R. C.
(2002). The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore. JEM
196: 1127-1140
[Abstract]
[Full Text]
-
Frolova, E. I., Fayzulin, R. Z., Cook, S. H., Griffin, D. E., Rice, C. M., Frolov, I.
(2002). Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection. J. Virol.
76: 11254-11264
[Abstract]
[Full Text]
-
Labrada, L., Liang, X. H., Zheng, W., Johnston, C., Levine, B.
(2002). Age-Dependent Resistance to Lethal Alphavirus Encephalitis in Mice: Analysis of Gene Expression in the Central Nervous System and Identification of a Novel Interferon-Inducible Protective Gene, Mouse ISG12. J. Virol.
76: 11688-11703
[Abstract]
[Full Text]
-
Zhou, J., Stohlman, S. A., Atkinson, R., Hinton, D. R., Marten, N. W.
(2002). Matrix Metalloproteinase Expression Correlates with Virulence following Neurotropic Mouse Hepatitis Virus Infection. J. Virol.
76: 7374-7384
[Abstract]
[Full Text]